XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.1
Significant Agreements - Supplemental Information related to the BMS Collaboration Agreement (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration receivable — related party $ 17   $ 0
Deferred revenue — related party 8,214   7,092
Deferred revenue, net of current — related party 60,658   63,218
Juno Therapeutics, Inc. | Collaborative Arrangement, Research Collaboration and License Agreement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration receivable — related party 17   0
Deferred revenue — related party 8,214   7,092
Deferred revenue, net of current — related party 60,658   $ 63,218
Revenue recognized that was included in contract liability at the beginning of the period 1,419 $ 0  
Revenue recognized from performance obligations fully or partially satisfied in previous periods $ 0 $ 0